Tammuella Chrisentery-Singleton/LinkedIn
Sep 15, 2026, 07:52
Tammuella Chrisentery-Singleton: Honored to Present at AHAD-AP Bangkok
Tammuella Chrisentery-Singleton, Chief Science Officer at American Thrombosis and Hemostasis Network (ATHN), Co- Director Hemostasis and Thrombosis Program at Ochsner Health, shared a post on LinkedIn:
“Honored to have had the opportunity to present at AHAD-AP in Bangkok!
Connecting with colleagues from around the world who share a commitment to advancing care for people living with hemophilia and other bleeding disorders is always incredibly inspiring.
I am truly grateful—and feel blessed—to be a hemophilia provider and part of a global community committed to advancing science, improving care, and expanding what is possible for our patients.”
Find more posts featuring Tammuella Chrisentery-Singleton on Hemostasis Today.
Advancing Care
AHAD-AP
bleeding disorders
Global Health
healthcare
Healthcare Professionals
Hematology
hematology community
Hemophilia
Hemophilia care
Hemostasis News
Hemostasis Today
Medical Conference
medical education
Patient Care
Rare Diseases
scientific collaboration
Tammuella Chrisentery-Singleton
-
Sep 15, 2026, 07:38Aaron Paul Kithcart: Connecting Science and Collaboration in Nagasaki
-
Sep 15, 2026, 02:59Caterina Casari: Curious about How Gene Editing is Revolutionizing Our Field?
-
Sep 15, 2026, 02:53Alejandro González Veliz: Can Lifestyle Changes Actually Reverse Atherosclerosis?
-
Sep 15, 2026, 02:08Eugenia Gianos: ACC CVPrevention Council’s New Statin Resources
-
Sep 15, 2026, 01:58Shinya Goto: Country Specific Randomized Trial Show the Merit of DOAC in Intermediate Risk of A
-
Sep 15, 2026, 01:37Lesley Van Wyk: Exploring Sickle Cell Disease – The HbS Story
-
Sep 15, 2026, 01:31Luca Seffin: To the Science, the People, and the Journey – Thank You SR-Tiget
-
Sep 14, 2026, 23:49Heghine Khachatryan: New evidance – Antiphospholipid Antibodies and Ischemic Stroke
-
Sep 14, 2026, 23:42Eman M. Elsabbagh: Successful HCT Does Not End at Engraftment